Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A) [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting immunogenicity and safety data for the inactivated Hepatitis A vaccine VITHA-A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• VITHA-A

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hepatitis A Vaccine | Phase 3 | Status: COMPLETED